The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Amlodipine 5 mg tablets



WPR Healthcare LimitedPPA0565/059/001

Main Information

Trade NameAmlodipine 5 mg tablets
Active SubstancesAmlodipine as amlodipine besilate
Dosage FormTablet
Licence HolderWPR Healthcare Limited
Licence NumberPPA0565/059/001

Group Information

ATC CodeC08CA Dihydropyridine derivatives
C08CA01 amlodipine

Status

License statusWithdrawn
Withdrawn Date31/12/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0045-001-008
Interchangeable List DocumentPDF of Interchangeable List
« Back